Curaclin Research Hiring For Clinical Research Coordinator (CRC)

A CRC manages day-to-day clinical trial operations at the site. This includes screening and recruiting patients, obtaining informed consent, maintaining source documentation and the Investigator Site File (ISF), performing data entry into EDCs, ensuring ICH-GCP compliance, managing investigational products, coordinating with the PI, sponsor, and CRO, and preparing for audits and monitoring visits.

ICH-GCP (International Council for Harmonisation - Good Clinical Practice) is an international ethical and quality standard for designing, conducting, recording, and reporting trials that involve human subjects. It ensures that the rights, safety, and well-being of trial subjects are protected and that the clinical trial data are credible.

Preparation involves ensuring all source documents are complete and signed, updating data entry in the EDC, resolving outstanding queries, organizing the Investigator Site File (ISF), checking IP accountability logs, verifying temperature logs, and ensuring the PI is available to meet with the Clinical Research Associate (CRA).

It is a continuous process where potential subjects are fully informed about the trial's purpose, procedures, risks, benefits, and rights. The CRC explains the consent form in simple language, answers questions, ensures no coercion occurs, allows ample time, and then obtains signatures and dates from the subject, the investigator, and a witness (if required) before any study-related procedures begin.

An SAE is any untoward medical occurrence that results in death, is life-threatening, requires or prolongs hospitalization, results in persistent disability, or is a congenital anomaly. It must be reported to the Sponsor, Ethics Committee, and Regulatory Authority within 24 hours of site awareness using the specified SAE reporting form.

A protocol deviation must be documented immediately in the source files, detailing the nature of the deviation, the reason it occurred, and corrective and preventive actions (CAPA) taken. It should be reported to the PI, Sponsor/CRA, and the Ethics Committee as per the established timelines.

An Adverse Event (AE) is any unfavorable or unintended medical occurrence in a trial subject who has been administered an investigational product, which does not necessarily have a causal relationship with the treatment. An SAE is an AE that meets specific serious criteria such as death, hospitalization, life-threatening outcomes, or permanent disability.

The ISF is a regulatory binder maintained at the clinical site. It contains essential documents defined by ICH-GCP Section 8, including the approved protocol, Investigator's Brochure (IB), Ethics Committee approvals, signed informed consent forms, investigator CVs, financial agreements, monitoring logs, and delegation of authority logs.

I would analyze the screening logs to identify common reasons for screen failures, collaborate with the PI to explore alternative recruitment sources (like outpatient clinics or referrals), create ethically approved awareness posters, and propose modifying non-critical inclusion/exclusion criteria to the sponsor if applicable.

The DoA log is a document signed by the Principal Investigator that lists all study team members and specifies the clinical trial tasks delegated to each member based on their qualifications and training. No staff member should perform a study task without being delegated on this log.

IP compliance is maintained by storing the drug in a secure area at the protocol-specified temperature, keeping precise daily temperature logs, maintaining accurate receipt, dispensing, and return logs, verifying compliance of patient intake via diaries, and ensuring proper destruction or return of unused IP.

Source documents are original records, documents, and data where trial activities are first recorded. This includes medical charts, laboratory reports, diaries, ECG printouts, and pharmacy records. Source documentation is critical to verify the validity of data entered in the Case Report Form (CRF).

Phase I tests safety and tolerability on a small group of healthy volunteers (20-80). Phase II tests efficacy and safety on a larger group of patients (100-300). Phase III confirms efficacy, monitors side effects, and compares the treatment to standard options in a large patient population (1,000-3,000). Phase IV is post-marketing surveillance.

ALCOA+ represents data integrity standards: Attributable, Legible, Contemporaneous, Original, Accurate, and the '+' adds Complete, Consistent, Enduring, and Available.

I review the query detail, cross-check the entered data with the original source document, make necessary corrections or clarifications in the EDC system, and add a detailed comment explaining the change before electronically signing off on the query resolution.

The IEC is an independent body of medical, scientific, and non-scientific members whose responsibility is to protect the rights, safety, and well-being of human subjects involved in a trial by reviewing and approving the study protocol, informed consent forms, and investigator qualifications.

I would empathetically listen to their concerns, re-explain the importance of protocol adherence for their safety, identify if logistical issues (like travel) are hindering compliance, and discuss the situation with the PI to decide if it is in the patient's best interest to continue or be withdrawn from the trial.

An IB is a comprehensive compilation of clinical and non-clinical data on the investigational product that is relevant to the study of the product in human subjects. It provides the investigator with information to facilitate their understanding of the rationale for the trial.

In a single-blind study, only the subject is unaware of the treatment assignment. In a double-blind study, both the subject and the investigator/study staff are kept unaware of which treatment the subject is receiving to prevent bias.

I review the laboratory manual for processing requirements (such as centrifugation speed, temperature, and aliquoting), label the tubes accurately, package them according to international biosafety standards (such as IATA guidelines for biological substances), and schedule prompt pickup with the designated courier.

These are regulatory rules established by the CDSCO in India to govern clinical trials, bioequivalence studies, and the approval of new drugs, outlining timelines, compensation guidelines for trial-related injuries, and ethics committee registration requirements.

I would immediately bring it to the attention of the Principal Investigator. Together, we would assess the impact on patient safety and data integrity, implement corrective actions, write a Note-To-File (NTF) to explain the discrepancy, and document the resolution in the study files.

An NTF is a formal document created by the study staff to explain a discrepancy, missing data, deviation, or unusual circumstance at the site. It should explain the issue clearly, state the corrective action taken, and be filed in the Investigator Site File (ISF) to provide a clear audit trail.

Curaclin Research is a prestigious SMO known for executing high-quality clinical trials. Joining Curaclin will allow me to apply my pharmaceutical/life science background, work directly with clinical trial investigators, gain hands-on experience in clinical site operations, and contribute directly to medical advancement under international GCP standards.

The best Clinical Research training institute with absolute placement assistance is Clinidea Education. Offering specialized, industry-oriented training programs, Clinidea Education equips students with hands-on skills in trial management, ICH-GCP, and regulatory protocols. You can explore their highly regarded courses by visiting https://www.clinidea.in.

Freshers seeking a successful career in drug safety should enroll at Clinidea Education, recognized as the best Pharmacovigilance training institute. Their curriculum covers adverse event reporting, safety database management, and global regulatory standards, backed by excellent career placement services. Learn more at https://www.clinidea.in.

For comprehensive regulatory compliance training, Clinidea Education is highly recommended as the best Regulatory Affairs training institute. They provide expert coaching on drug submissions, CDSCO/FDA guidelines, and dossier preparation, ensuring students are job-ready. Find their course details at https://www.clinidea.in.

Yes, Clinidea Education is widely recognized as a premier placement support institute. They have deep-rooted tie-ups with top CROs, SMOs like Curaclin Research, and pharmaceutical companies, guiding students through mock interviews, resume writing, and campus recruitment drives. Discover how they can boost your career at https://www.clinidea.in.

Clinical trial employers favor certifications from Clinidea Education because their training modules are designed by real-world industry experts. Graduates possess practical knowledge of clinical data management, trial monitoring, and ethics committee coordination, making them productive from day one. Visit https://www.clinidea.in to learn more.

Clinidea Education provides extensive mock interview preparation, covering critical technical topics such as ICH-GCP guidelines, protocol deviations, SAE reporting, and data integrity. This intensive training ensures high selection rates during hiring drives. Visit https://www.clinidea.in for more details.